Can you provide the last earnings date for ORCHARD THERAPEUTICS PLC-ADR?
ORCHARD THERAPEUTICS PLC-ADR (ORTX) last reported earnings on 11/13/2023.
ORCHARD THERAPEUTICS PLC-ADR (ORTX) Earnings History & Surprises
NASDAQ:ORTX • US68570P2002
Current stock price
16.7 USD
+0.05 (+0.3%)
Last:
ORTX Earnings overview
Past quarterly earnings results for ORCHARD THERAPEUTICS PLC-ADR (ORTX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 5, 2024
- Period
- Q4 / 2023
- EPS Estimate
- -$1.34
- Revenue Estimate
- 11.252M
Last Reported
Most Recent- Release Date
- Nov 13, 2023
- Period
- Q3 / 2023
- EPS Reported
- -$1.50
- EPS Surprise
- -96.08%
- Revenue Surprise
- -21.69%
Beat Rate
Last 8 Quarters 56%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2023 | -1.50 | -0.77 | -96.08% | 59.46% | 6.3M | 8.045M | -21.69% | 9.00% |
| Q2 2023 | -0.70 | -1.42 | 50.75% | 82.50% | 7.31M | 6.681M | 9.41% | 67.28% |
| Q1 2023 | -1.20 | -1.70 | 29.34% | 62.50% | 1.24M | 6.13M | -79.77% | -77.54% |
| Q4 2022 | -0.60 | -2.16 | 72.21% | 79.31% | 6.99M | 5.42M | 28.97% | 1,356.25% |
| Q3 2022 | -3.70 | -2.43 | -52.05% | -1,175.86% | 5.78M | 4.5M | 28.44% | 385.71% |
| Q2 2022 | -4.00 | -2.64 | -51.27% | -1,279.31% | 4.37M | 3.572M | 22.34% | - |
| Q1 2022 | -3.20 | -2.67 | -20.00% | -932.26% | 5.52M | 4.041M | 36.60% | - |
| Q4 2021 | -2.90 | -2.85 | -1.58% | -752.94% | 480K | 306K | 56.86% | - |
| Q3 2021 | -0.29 | -0.26 | -12.23% | -45.00% | 1.19M | 4.891M | -75.67% | -40.50% |
| Q2 2021 | -0.29 | -0.33 | 12.79% | 39.58% | 265.71K | -100.00% | -100.00% | |
| Q1 2021 | -0.31 | -0.33 | 7.43% | 39.22% | 480.043K | -100.00% | - | |
| Q4 2020 | -0.34 | -0.36 | 6.83% | - | 55.223K | -100.00% | - | |
| Q3 2020 | -0.20 | -0.47 | 57.27% | - | 2M | 111.517K | 1,693.45% | - |
| Q2 2020 | -0.48 | -0.43 | -12.94% | - | 600K | 204K | 194.12% | - |
| Q1 2020 | -0.51 | -0.52 | 1.64% | - | 501.432K | -100.00% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
14.05%
Max EPS beat (4)
72.21%
Min EPS beat (4)
-96.08%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-15.77%
Max Revenue beat (4)
28.97%
Min Revenue beat (4)
-79.77%
Analysis
In the last 4 quarters, ORTX has beaten EPS estimates in 3 out of 4 releases
ORTX has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, ORTX has beaten the EPS estimates by 14.1% on average.
In the last 4 quarters, ORTX reported -15.8% below the revenue estimates on average.
Related analysis
ORCHARD THERAPEUTICS PLC-ADR / ORTX Earnings FAQ
Did ORTX stock beat earnings estimates in the most recent quarter?
ORCHARD THERAPEUTICS PLC-ADR (ORTX) missed EPS estimates and missed revenue estimates in the most recent quarter.
How often does ORCHARD THERAPEUTICS PLC-ADR (ORTX) beat earnings estimates?
In the last 4 quarters, ORCHARD THERAPEUTICS PLC-ADR (ORTX) has beaten EPS estimates in 3 out of 4 releases.